Louisiana Zofran Lawsuits Filed for Birth Defects - Attorneys Handling Zofran Lawsuits in Louisiana Offer No-Cost, No-Obligation Zofran Case Review to Residents of Louisiana
Zofran (ondansetron) is a prescription drug used to prevent nausea and vomiting. While Zofran has been approved by the FDA to treat patients undergoing chemotherapy treatment, radiation therapy, or surgery, it is also widely used to control nausea and vomiting in pregnant women. Recent research shows that Zofran is dangerous for fetuses and mothers, increasing the risk of birth defects, heart defects, and dangerous medical conditions.
The purveyor of Zofran, GlaxoSmithKline, paid the U.S. Justice Department $2 billion to settle a lawsuit related to the promotion of Zofran for off-label uses, including its use to control vomiting in pregnant women. The use of Zofran during pregnancy has been the subject of multiple studies conducted globally since 2004. In 2013, the FDA added Zofran to a list of drugs being monitored for “potential… serious risks” based on adverse event reporting in the federal FAERS program.
If you or a loved one in Louisiana has had a baby born with birth defects, heart defects or who has suffered health problems after exposure to Zofran, you may be eligible to receive compensation through filing a Louisiana Zofran birth defects lawsuit. Attorneys handling Louisiana Zofran heart defects lawsuit claims provide free, no-obligation case reviews to women and families in Louisiana who match this description. Our Zofran birth defects attorneys handling Louisiana claims not only have a significant track record of success in the realm of national pharmaceutical safety litigation but also endeavor to provide legal representation that is sensitive to the needs of mothers and families. Should you choose to retain our Louisiana Zofran birth defects lawyers, there is never any fee unless we win compensation on your behalf.
Individuals and families in Louisiana who have had a baby born with birth defects or heart defects after exposure to Zofran may be entitled to compensation through filing Louisiana Zofran birth defects lawsuits. Persons meeting this description are eligible for a free, no-obligation case review from an experienced attorney handling Zofran birth defects lawsuits in Louisiana. Louisiana Zofran birth defects lawsuits
against the drug maker GlaxoSmithKline are being filed by our firm at this time.
If you believe your family may have grounds to file a Louisiana Zofran birth defects lawsuit, this page will provide answers to many common questions on Louisiana Zofran lawsuit
claims, heart defects, and birth defects. If questions regarding your individual circumstances remain after reading this page, please contact our attorneys providing Louisiana Zofran birth defects lawsuit representation to ask any further questions; consultations are free and require no further obligation.
Our team of Louisiana Zofran birth defects lawyers are experienced in battling pharmaceutical giants such as GlaxoSmithKline. Backed by the expertise, strong track record of success, and significant resources of a respected national consumer safety law firm, these Louisiana Zofran birth defects attorneys are equipped to handle the complexities of your claim, whatever they may be. Committed to achieving justice on behalf of American families, our Louisiana Zofran birth defects lawyers provide legal services that are sensitive to the needs of Louisiana mothers and families in a difficult time of life. A Louisiana Zofran birth defects attorney
is available to discuss your case without fee or obligation and there are never any legal fees unless we collect for you.
Recent research shows that taking Zofran during pregnancy may increase the risk of birth defects and serious health conditions for the mother and fetus. Congenital heart defects and physical deformities are among the birth defects that researchers believe are caused by Zofran, including cleft lip, cleft palate, musculoskeletal defects, jaundice, and other physical abnormalities. Health conditions caused by Zofran in the mother can also risk the health and safety of the fetus. This section provides an overview of the scientific research behind the Zofran birth defects
link and information for Louisiana families who believe their child may have suffered from Zofran birth defects.
Studies show that taking Zofran during pregnancy may increase the risk of heart defects in fetuses. In addition to an increased risk for physical deformities, there are several potential Zofran heart defects that can occur. Zofran heart defects include atrial septal defect, ventricular septal defect, and heart murmur. The drug is also currently the subject of FDA monitoring for other side effects for the mother which can also endanger the fetus, based on adverse event reports from patients who have suffered from health problems while taking the drug. This page outlines the research on Zofran heart defects
and other pregnancy risks to date that are faced by mothers in Louisiana.